{
  "retracted": false,
  "timestamp": 1528243200000,
  "updates": [
    {
      "timestamp": 1574843065386,
      "identifier": {
        "doi": "10.1007/s40267-018-0526-y"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40267-018-0522-2"
  },
  "journal": "Drugs & Therapy Perspectives",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Dinutuximab beta in high-risk neuroblastoma: a profile of its use"
}
